<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>05944756594176</udiDi>
    <basicUdiDi>B-05944756594176</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1574</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:50:28.747Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594169</udiDi>
    <basicUdiDi>B-05944756594169</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1573</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:50:26.343Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594152</udiDi>
    <basicUdiDi>B-05944756594152</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1572</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:50:24.747Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594145</udiDi>
    <basicUdiDi>B-05944756594145</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1571</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:50:23.937Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594138</udiDi>
    <basicUdiDi>B-05944756594138</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1570</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:50:22.340Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594121</udiDi>
    <basicUdiDi>B-05944756594121</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1569</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:50:19.932Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594114</udiDi>
    <basicUdiDi>B-05944756594114</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1568</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:50:18.347Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594107</udiDi>
    <basicUdiDi>B-05944756594107</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1567</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:50:17.530Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594091</udiDi>
    <basicUdiDi>B-05944756594091</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1566</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:50:15.935Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756590260</udiDi>
    <basicUdiDi>B-05944756590260</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 152</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:43:11.278Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756590253</udiDi>
    <basicUdiDi>B-05944756590253</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 151-5</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:42:56.951Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756590246</udiDi>
    <basicUdiDi>B-05944756590246</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 151</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:42:40.860Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756590239</udiDi>
    <basicUdiDi>B-05944756590239</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 150-5</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:42:39.569Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756590222</udiDi>
    <basicUdiDi>B-05944756590222</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 150</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:42:38.020Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756590215</udiDi>
    <basicUdiDi>B-05944756590215</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 149-5</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:42:35.531Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756590208</udiDi>
    <basicUdiDi>B-05944756590208</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 149</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:42:34.093Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756590192</udiDi>
    <basicUdiDi>B-05944756590192</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 148</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:42:33.139Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756590185</udiDi>
    <basicUdiDi>B-05944756590185</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 147</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:42:31.539Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756590178</udiDi>
    <basicUdiDi>B-05944756590178</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 146</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:42:29.131Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756590161</udiDi>
    <basicUdiDi>B-05944756590161</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 145</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:42:27.857Z</lastUpdated>
  </row>
</eudamedExport>